Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials
about
Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain.Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
P2860
Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Flexible dosing with fesoterod ...... w of data from clinical trials
@ast
Flexible dosing with fesoterod ...... w of data from clinical trials
@en
Flexible dosing with fesoterod ...... w of data from clinical trials
@nl
type
label
Flexible dosing with fesoterod ...... w of data from clinical trials
@ast
Flexible dosing with fesoterod ...... w of data from clinical trials
@en
Flexible dosing with fesoterod ...... w of data from clinical trials
@nl
prefLabel
Flexible dosing with fesoterod ...... w of data from clinical trials
@ast
Flexible dosing with fesoterod ...... w of data from clinical trials
@en
Flexible dosing with fesoterod ...... w of data from clinical trials
@nl
P2093
P2860
P3181
P356
P1476
Flexible dosing with fesoterod ...... w of data from clinical trials
@en
P2093
D. Scholfield
J. J. Wyndaele
S. MacDiarmid
T. Schneider
P2860
P304
P3181
P356
10.1111/IJCP.12425
P407
P577
2014-07-01T00:00:00Z